12576 Federal Register / Vol. 77, No. 41 / Thursday, March 1, 2012 / Notices 

CONSUMER PRODUCT SAFETY 

COMMISSION 

Sunshine Act Meetings 

TIME AND DATE: Wednesday, March 7, 

2012, 10 a.m.–11 a.m. 

PLACE: Hearing Room 420, Bethesda 

Towers, 4330 East West Highway, 

Bethesda, Maryland. 

STATUS: Commission Meeting—Open to 

the Public. 

MATTERS TO BE CONSIDERED: Decisional 

Matter: Fiscal Year 2012 Operating Plan. 

A live webcast of the Meeting can be 

viewed at www.cpsc.gov/webcast. 

TIME AND DATE: Wednesday, March 7, 

2012; 11 a.m.—12 p.m. 

PLACE: Hearing Room 420, Bethesda 

Towers, 4330 East West Highway, 

Bethesda, Maryland. 

STATUS: Closed to the Public. 

MATTER TO BE CONSIDERED: Compliance 

Status Report: The Commission staff 

will brief the Commission on the status 

of compliance matters. 

For a recorded message containing the 

latest agenda information, call (301) 

504–7948. 

CONTACT PERSON FOR MORE INFORMATION: 

Todd A. Stevenson, Office of the 

Secretary, U.S. Consumer Product 

Safety Commission, 4330 East West 

Highway, Bethesda, MD 20814, (301) 

504–7923. 

Dated: February 28, 2012. 

Todd A. Stevenson, 

Secretary. 

[FR Doc. 2012–5137 Filed 2–28–12; 2:00 pm] 

BILLING CODE 6355–01–P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Veterans’ Advisory Board on Dose 

Reconstruction; Meeting 

AGENCY: Defense Threat Reduction 

Agency, DoD. 

ACTION: Advisory Board Meeting Notice. 

SUMMARY: Under the provisions of the 

Federal Advisory Committee Act of 

1972 (5 U.S.C., Appendix, as amended), 

the Sunshine in the Government Act of 

1976 (5 U.S.C. 552b, as amended), the 

Defense Threat Reduction Agency 

(DTRA), and the Department of Veterans 

Affairs (VA) announce the following 

advisory board meeting of the Veterans’ 

Advisory Board on Dose Reconstruction 

(VBDR). 

DATES: Friday, March 23, 2012, from 

8 a.m. to 12 p.m. and from 1 p.m. to 

6 p.m. and Saturday, March 24, 2012, 

from 9 a.m. to 12 p.m. The public is 

invited to attend. A public comment 

session is scheduled from 4 p.m. to 

5 p.m. on Friday and from 9:30 a.m. to 

10:20 a.m. on Saturday. 

ADDRESSES: Embassy Suites Riverwalk 

Hotel, E. Houston Street, San Antonio, 

TX 78205. 

FOR FURTHER INFORMATION CONTACT: The 

Veterans’ Advisory Board on Dose 

Reconstruction Toll Free at 1–866–657– 

VBDR (8237). Additional information 

may be found at http://vbdr.org. 

SUPPLEMENTARY INFORMATION: 

Purpose of Meeting: To obtain, 

review, and evaluate information related 

to the Board’s mission to provide 

guidance and review of the dose 

reconstruction and claims compensation 

programs for veterans of U.S.-sponsored 

atmospheric nuclear weapons tests from 

1945–1962; veterans of the 1945–1946 

occupation of Hiroshima and Nagasaki, 

Japan; and veterans who were prisoners 

of war in those regions at the conclusion 

of World War II. In addition, the 

advisory board will assist the VA and 

DTRA in communicating with the 

veterans. The meeting will also include 

public presentations regarding dose 

reconstruction efforts related to the 

Fukushima incident in Japan and the 

McMurdo Station in Antarctica. 

Meeting Agenda: The meeting will 

open on Friday morning with a Call to 

Order from the Designated Federal 

Official. Dr. Charles Roadman, the 

VBDR Chairman will make opening 

remarks and will introduce the members 

of the Board. After introductions, the 

remainder of the morning will include 

the following briefings: ‘‘Review of 

Atomic Veterans Epidemiology Study’’ 

by Dr. John Boice; ‘‘Review of Atomic 

Veterans Demographic Study’’ by Dr. 

John Lathrop, ‘‘Review of the Navy’s 

PM–3A (McMurdo Sound Nuclear 

Reactor) Dose Reconstruction Effort’’ by 

LCDR Greg Fairchild, USN; ‘‘Review of 

the DoD Population of Interest Dose 

Reconstruction from the Fukushima 

incident in Japan’’ by Dr. Gerald Falo, 

Dr. Steven Rademacher, and CDR James 

Cassata, USN, and an ‘‘Update on the 

Nuclear Test Personnel Review (NTPR) 

Dose Reconstruction Program’’, by Dr. 

Paul Blake. The afternoon session will 

include additional briefings: ‘‘Update on 

the VA Radiation Claims Compensation 

Program for Veterans’’, by Mr. Brad 

Flohr, ‘‘Presentation on the VA/DTRA/ 

VBDR Atomic Veterans 

Communications Plan’’ by Mr. Jim 

Benson, VA, Mr. Richard Cole, DTRA 

and Mr. Kenneth Groves and ‘‘Overview 

of the VA’s Office of Public Health’’ by 

Dr. Paul Ciminera. Next, the four active 

subcommittees established during the 

inaugural VBDR session will report on 

their activities since March 2011. These 

subcommittees consist of the following: 

Subcommittee on DTRA Dose 

Reconstruction Procedures; the 

Subcommittee on VA Claims 

Adjudication Procedures; the 

Subcommittee on Quality Management 

and VA Process Integration with DTRA 

Nuclear Test Personnel Review 

Program; and the Subcommittee on 

Communication and Outreach. The 

afternoon session also includes a one 

hour open public comment session. The 

remainder of the Friday afternoon 

meeting will be devoted to an overview 

discussion on the VBDR activities. The 

meeting will reconvene on Saturday 

morning with an introduction to the 

Special Session by the VBDR Chairman, 

Dr. Charles Roadman. The morning 

session includes an open public 

comment period and opportunities for 

discussion with VA and DTRA NTPR 

representatives. The Designated Federal 

Official will close the meeting at 12 p.m. 

Meeting Accessibility: Pursuant to 5 

U.S.C. 552b, as amended, and 41 CFR 

102–3.140 through 102–3.165, and the 

availability of space, this meeting is 

open to the public. Seating is limited by 

the size of the meeting room. All 

persons must sign in legibly at the 

registration desk. 

Written Statements: Pursuant to 41 

CFR 102–3.105(j) and 102–3.140(c), 

interested persons may submit a written 

statement for consideration by the 

Veterans’ Advisory Board on Dose 

Reconstruction. Written statements 

should be no longer than two typewritten pages and must address the 

following: the issue, discussion, and 

recommended course of action for the 

VBDR. Supporting documentation may 

also be included as needed to establish 

the appropriate historical context and to 

provide any necessary background 

information. 

Individuals submitting a written 

statement may submit their statement to 

the Board at 801 N. Quincy Street, Suite 

700, Arlington, VA 22203, at any time. 

However, if a written statement is not 

received at least 10 calendar days prior 

to the meeting, which is the subject of 

this notice, then it may not be provided 

to or considered by the Veterans’ 

Advisory Board on Dose Reconstruction 

until its next open meeting. 

The Chairperson will review all 

timely submissions with the Designated 

Federal Officer, and ensure they are 

provided to members of the Veterans’ 

Advisory Board on Dose Reconstruction 

before the meeting that is the subject of 

this notice. After reviewing the written 

comments, the Chairperson and the 

Designated Federal Officer may choose 

mstockstill on DSK4VPTVN1PROD with NOTICES